ProMIS Neurosciences Soars 160% After FDA Fast Track Designation for Alzheimer’s Drug
PMN310 aims to deliver a safer, next-generation treatment by targeting toxic amyloid-beta in early-stage Alzheimer’s patients Shares of ProMIS Neurosciences ...
PMN310 aims to deliver a safer, next-generation treatment by targeting toxic amyloid-beta in early-stage Alzheimer’s patients Shares of ProMIS Neurosciences ...
With over $72 billion in BTC, the corporate giant strengthens its position as the world’s largest institutional Bitcoin holder Michael ...
New menu items and rewards promotions help Domino’s gain market share amid economic uncertainty and inflation Domino’s Pizza (DPZ) topped ...
Retailer leans into viral "Staplegate" moment with charity auction, boosting its identity as a collector-focused brand GameStop (GME) has once ...
Rare earth miner jumps 25% after securing multi-year agreement with Apple as tech giant shifts focus to American manufacturing MP ...
EV maker collaborates with Google for a first-of-its-kind map experience that blends Rivian’s EV-specific features with Google’s powerful location data ...
Despite record asset growth and aggressive expansion into private markets, performance fees and revenue fell short of expectations, sending shares ...
Deal strengthens Ferrero’s U.S. presence as sugary cereal giant WK Kellogg joins candy empire Ferrero, the Italian confectionery giant known ...
Software giant shifts focus back to smaller, strategic acquisitions amid investor pressure and pricing concerns Autodesk (ADSK) shares rose nearly ...
Crypto rallies alongside tech giants as favorable policy and regulation fuel investor confidence Bitcoin (BTC-USD) surged to a fresh all-time ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?